the firm's newest enzyme replacement therapy Palynziq (for adults with severe PKU) was approved in the US in 2018 and Europe in 2019 and is mitigating the hit. Vimizim, for Morquio A syndrome ...

FLEMING 1 noted that the growth of B. coli and a number of other bacteria belonging to the colityphoid group was not inhibited by penicillin. This observation has been confirmed. Further work has ...

Enzyme mechanisms are the chemical transformations, and the steps within them, generated by enzymatic action on substrates. The mechanism of enzyme catalysis is similar in principle to other types ...

Advanced Enzyme Technologies Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 3,978.70 Crore) operating in Agriculture ...

The discovery of CA-KR1, a highly thermo- and alkali-stable carbonic anhydrase, signifies a leap forward toward the facilitation of biomimetic HPC carbon ...

Galactosialidosis (GS) is a lysosomal storage disease associated with a combined deficiency of beta-galactosidase and neuraminidase, secondary to a defect in protective protein/cathepsin A. Combined ...

In this report, we describe a case of LSD, that is, galactosialidosis presenting as non-immune hydrops and its diagnosis. In utero diagnosis of the disorder without an index case is challenging. The ...

sialidosis type 1 or juvenile adult galactosialidosis and Gaucher disease type III. The drug candidate is administered orally as a capsule. The drug candidate targets glucosylceramide synthase (GCS).